most effective glp-1 for obesity treatment 2025 trends 2025: real-world data, patient outcomes & future therapies Obesity GLP-1 Market Size to

Studies link excess subcutaneous belly fat to insulin resistance and type 2 diabetes, as well as imbalances in estrogen, leptin and other key hormones that influence how your body stores fat and regulates appetite

The results will be summarized in the following sections

Recent data from the Centers for Disease Control and Prevention (CDC) gives us a clear snapshot of who is using these injectable medications

Tirzepatide takes it a step further by activating both GLP-1 and GIP receptors, making it even more effective in reducing hunger and improving insulin response, which can lead to greater weight loss results